Life Science Compliance Update

« Previous article | Home| Next article »

August 09, 2017

EU Court Issues Over-Reaching Ruling on Vaccines


In June 2017, the Court of Justice of the European Union ruled that courts may consider vaccines to be the cause of an illness, even if there is no scientific evidence confirming a link. The Court said that if the development of a disease is timely to the person’s receiving a vaccine, it may serve as enough proof – provided that the person was previously healthy with a lack of history of the disease in their family and if a significant number of disease cases are reported among people receiving a particular vaccine.

The ruling stemmed from the case of a French man known as J.W., who was vaccinated against hepatitis B in 1998 and developed multiple sclerosis a year later. Multiple sclerosis is known to scar nerve tissue and cause a range of symptoms, from vision problems to paralysis. In 2006, J.W. sued pharmaceutical company Sanofi Pasteur, which produced the vaccine, blaming it for his decline in health. J.W. died in 2011.

The case was brought before the Court of Appeal in France, which ruled that there was no scientific consensus supporting a causal link and no evidence of a causal link between the hepatitis B vaccine and the man's multiple sclerosis, therefore dismissing the action. This judgment was appealed and brought to the French Court of Cessation, which took it to the European Court of Justice.

The Court of Justice said that "specific and consistent evidence" relating to timeliness, a prior healthy status, lack of family history and multiple cases may prove to be enough, according to a statement. J.W.'s case referred to the first three criteria.

While the court's decision is not a ruling on J.W.'s case, it is meant to provide guidance for all EU courts considering similar issues.

In a statement, a representative from Sanofi Pasteur said: "It is not our role to comment on this legal decision. However, Sanofi Pasteur wishes to reiterate that its vaccines are safe and effective and protect against infectious diseases. Our hepatitis B vaccines are safe and well tolerated. They have been approved by Health Authorities and are marketed for more than 30 years."

Expert Statements

"No causal link exists" between the hepatitis B vaccine and multiple sclerosis, "but a few cases after vaccination would not be surprising, especially when administered to teenagers, just before the age of onset age for many MS sufferers," said Keith Neal, emeritus professor in the epidemiology of infectious diseases at the University of Nottingham. "What they are saying is, the vaccine is responsible for the patient's MS if it can't be proved it isn't, and that is virtually impossible given what is worded. Potentially, this ruling affects all drugs and threatens the development of new drugs."

Peter Openshaw, president of the British Society for Immunology and professor of experimental medicine at Imperial College London, said, "it is very concerning that the European Court of Justice has ruled that judges can consider whether a vaccination led to someone developing a medical condition, even if there is no scientific evidence to support this."

"The scientific evidence does not support a link between the hepatitis B vaccine, or any other vaccine in current use, and multiple sclerosis," he said. "To say that there is a link between any vaccine and multiple sclerosis and at the same time to admit that there is no scientific evidence of such a link is illogical and confusing to the public."

"The only alleged evidence that would be worth taking seriously is the alleged numbers of other similar cases," he said. "Those data should be capable of detailed case comparisons for consistency, and probably also orthodox epidemiological study."

But without such a study, Fox added, "one might just as well say, 'If this vaccine causes MS, then why is it that millions of people have been vaccinated and did not get MS? And why are there so many people with MS who have never had this vaccination?' "

« Previous article | Home| Next article »


Feed You can follow this conversation by subscribing to the comment feed for this post.

The comments to this entry are closed.


Preview | Powered by FeedBlitz


February 2018
Sun Mon Tue Wed Thu Fri Sat
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28